CD151 and colorectal carcinoma: RNA-seq further demonstrated that CD151 modulated several molecular processes responsible for CRC progression, including TGFβR1 binding, cell motility, activation of calcium channel inhibitors, biological response to stress, immune system activation, signal transducer activities, and et al.